Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities
ClinicalTrials.gov study NCT02915224. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00934986. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01013441. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00089154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01671904. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00086775. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders
ClinicalTrials.gov study NCT00304005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
ClinicalTrials.gov study NCT05536349. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
ClinicalTrials.gov study NCT03545035. IPD Sharing: NO. Countries: 1. Publications: 0.
Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome
ClinicalTrials.gov study NCT02846623. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
ClinicalTrials.gov study NCT01397149. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00005579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05869279. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
ClinicalTrials.gov study NCT02981745. IPD Sharing: NO. Countries: 1. Publications: 0.
Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00003620. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00086840. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting
ClinicalTrials.gov study NCT03720561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Transplantation for Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00186303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02034227. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
ClinicalTrials.gov study NCT04269902. IPD Sharing: YES. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.